EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 273 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2019. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43,952 | -53.1% | 12,927 | +1.5% | 0.00% | -100.0% |
| Q2 2023 | $93,639 | -30.5% | 12,740 | -2.1% | 0.00% | 0.0% |
| Q1 2023 | $134,773 | -9.9% | 13,009 | +2.7% | 0.00% | 0.0% |
| Q4 2022 | $149,538 | -42.0% | 12,662 | +3.0% | 0.00% | -66.7% |
| Q3 2022 | $258,000 | -33.7% | 12,288 | -2.0% | 0.00% | -25.0% |
| Q2 2022 | $389,000 | -27.6% | 12,536 | -4.2% | 0.00% | 0.0% |
| Q1 2022 | $537,000 | -5.0% | 13,088 | +0.6% | 0.00% | 0.0% |
| Q4 2021 | $565,000 | -14.1% | 13,008 | -1.0% | 0.00% | -20.0% |
| Q3 2021 | $658,000 | -19.9% | 13,137 | +0.7% | 0.01% | -28.6% |
| Q2 2021 | $821,000 | -32.6% | 13,040 | -0.6% | 0.01% | -36.4% |
| Q1 2021 | $1,218,000 | +4.2% | 13,114 | +0.5% | 0.01% | 0.0% |
| Q4 2020 | $1,169,000 | -15.8% | 13,046 | -3.0% | 0.01% | -21.4% |
| Q3 2020 | $1,389,000 | +76.0% | 13,446 | +34.8% | 0.01% | +27.3% |
| Q2 2020 | $789,000 | +32.4% | 9,976 | -3.2% | 0.01% | +10.0% |
| Q1 2020 | $596,000 | -62.3% | 10,302 | -64.8% | 0.01% | -47.4% |
| Q4 2019 | $1,579,000 | -41.4% | 29,261 | -43.2% | 0.02% | -42.4% |
| Q3 2019 | $2,693,000 | -20.6% | 51,512 | -26.6% | 0.03% | -15.4% |
| Q2 2019 | $3,390,000 | -3.4% | 70,164 | +0.9% | 0.04% | -7.1% |
| Q1 2019 | $3,511,000 | -14.2% | 69,505 | +0.7% | 0.04% | -20.8% |
| Q4 2018 | $4,093,000 | -2.6% | 69,040 | +8.1% | 0.05% | +32.5% |
| Q3 2018 | $4,203,000 | +61.8% | 63,853 | +24.1% | 0.04% | +53.8% |
| Q2 2018 | $2,598,000 | -10.8% | 51,454 | -7.0% | 0.03% | -10.3% |
| Q1 2018 | $2,914,000 | +6.0% | 55,338 | -6.4% | 0.03% | +7.4% |
| Q4 2017 | $2,748,000 | +273.9% | 59,138 | +225.6% | 0.03% | +200.0% |
| Q3 2017 | $735,000 | +19.3% | 18,160 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $616,000 | +17.6% | 18,160 | +0.6% | 0.01% | +28.6% |
| Q1 2017 | $524,000 | -10.1% | 18,060 | +1.7% | 0.01% | -22.2% |
| Q4 2016 | $583,000 | +4.1% | 17,760 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $560,000 | +22.5% | 17,760 | +9.2% | 0.01% | +50.0% |
| Q2 2016 | $457,000 | -20.2% | 16,260 | +3.2% | 0.01% | -14.3% |
| Q1 2016 | $573,000 | -5.6% | 15,760 | +4.0% | 0.01% | -12.5% |
| Q4 2015 | $607,000 | +46.3% | 15,160 | +4.1% | 0.01% | +33.3% |
| Q3 2015 | $415,000 | -25.6% | 14,560 | -29.0% | 0.01% | -14.3% |
| Q4 2014 | $558,000 | +29.2% | 20,500 | +1.0% | 0.01% | +40.0% |
| Q3 2014 | $432,000 | -5.1% | 20,300 | 0.0% | 0.01% | -16.7% |
| Q2 2014 | $455,000 | -10.8% | 20,300 | +0.5% | 0.01% | 0.0% |
| Q1 2014 | $510,000 | -3.0% | 20,200 | -11.8% | 0.01% | 0.0% |
| Q4 2013 | $526,000 | +8.5% | 22,900 | -10.2% | 0.01% | 0.0% |
| Q3 2013 | $485,000 | +42.2% | 25,500 | +7.6% | 0.01% | +20.0% |
| Q2 2013 | $341,000 | +0.9% | 23,700 | -2.1% | 0.01% | 0.0% |
| Q1 2013 | $338,000 | – | 24,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 25,250 | $784,000 | 2.30% |
| Global Alpha Capital Management Ltd. | 418,030 | $12,976,000 | 1.40% |
| AIMZ Investment Advisors, LLC | 70,588 | $2,191,000 | 1.05% |
| PALISADE CAPITAL MANAGEMENT, LP | 566,080 | $17,571,000 | 0.48% |
| RICE HALL JAMES & ASSOCIATES, LLC | 261,533 | $8,118,000 | 0.39% |
| EARNEST PARTNERS LLC | 1,844,621 | $57,257,000 | 0.38% |
| SummerHaven Investment Management, LLC | 14,476 | $449,000 | 0.30% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,085,874 | $33,706,000 | 0.26% |
| Ridgewood Investments LLC | 10,004 | $311,000 | 0.24% |
| DUALITY ADVISERS, LP | 65,650 | $2,038,000 | 0.20% |